← Back to Search

ICM Implantation for Heart Attack (AID MI Trial)

N/A
Recruiting
Led By Samir F Saba, MD
Research Sponsored by Samir Saba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
AMI (STEMI and NSTEMI)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

AID MI Trial Summary

This trialwill investigate if an implantable cardiac monitor can help reduce mortality in people after a heart attack.

Who is the study for?
This trial is for adults over 18 who've recently had a heart attack and are expected to leave the hospital within 7 days of the event. They must be willing to get an implantable cardiac monitor (ICM) within 21 days after their heart attack, and agree to give written consent. People with existing heart devices, those pregnant, or needing open-heart surgery can't participate.Check my eligibility
What is being tested?
The study is testing if monitoring patients with an ICM after a heart attack affects patient management and improves outcomes compared to standard care alone. The ICM is implanted shortly after the patient's discharge from the hospital.See study design
What are the potential side effects?
Potential side effects may include discomfort at the implant site, infection risk, allergic reaction to device materials, or interference with device function leading to inaccurate monitoring.

AID MI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a heart attack.

AID MI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cardiac Arrhythmia
Secondary outcome measures
Changes to patient management
Mortality
Other outcome measures
Depression and Anxiety Scale
Physical and Mental Health

AID MI Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ICMExperimental Treatment1 Intervention
Post-AMI patients in this arm will receive standard of care and an ICM
Group II: ControlActive Control1 Intervention
Post-AMI patients in this arm will receive standard of care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ICM Implantation
2008
Completed Phase 4
~50

Find a Location

Who is running the clinical trial?

Samir SabaLead Sponsor
3 Previous Clinical Trials
301 Total Patients Enrolled
AbbottIndustry Sponsor
750 Previous Clinical Trials
478,100 Total Patients Enrolled
Samir F Saba, MDPrincipal InvestigatorUniversity of Pittsburgh Medical Center
1 Previous Clinical Trials
42 Total Patients Enrolled

Media Library

ICM Clinical Trial Eligibility Overview. Trial Name: NCT05073419 — N/A
Heart Attack Research Study Groups: ICM, Control
Heart Attack Clinical Trial 2023: ICM Highlights & Side Effects. Trial Name: NCT05073419 — N/A
ICM 2023 Treatment Timeline for Medical Study. Trial Name: NCT05073419 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of participants enrolled in this investigation?

"Absolutely, the information available on clinicaltrials.gov suggests that this medical experiment is still in progress and actively searching for patients to join. This investigation was originally posted August 9th 2022 and its details have been revised as recently as October 6th of the same year. 200 participants are required from a single location to complete it."

Answered by AI

Are applications for the study still being accepted?

"Affirmative. Clinicaltrials.gov data shows that this medical trial, which was first published on August 9th 2022, is currently searching for individuals to enroll in the study. 200 patients need to be recruited from a single site."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Arrhythmia Detection After MI
Samir Saba 2022. "Arrhythmia Detection After MI". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05073419.
All > Heart Attack
~40 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top